She's fighting to stop the brain disease that killed her mother before it gets her. [USA TODAY]
Ionis Pharmaceuticals, Inc. (IONS)
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ionispharma.com
Company Research
Source: USA TODAY
CAMBRIDGE, Massachusetts ? Sonia Vallabh watched helplessly as her 51-year-old mother rapidly descended into dementia and died. It didn't take long for Vallabh to realize she was destined for the same rare genetic fate. Vallabh and her husband did what anyone would want to do in their situation: They decided to fight. Armed with little more than incredible intellect and determination they set out to conquer her destiny. A dozen years later, they've taken a major step in that direction, finding a way to shut off enough genetic signals to hold off the disease. And in the process of trying to rescue Vallabh, they may save many, many others as well. In a , Vallabh and her husband, Eric Minikel, and their co-authors offer a way to disrupt brain diseases like the one that killed her mother. The same approach should also work against diseases such as Huntington's, Parkinson's, ALS and even Alzheimer's, which result from the accumulation of toxic proteins. If it works as well as
Show less
Read more
Impact Snapshot
Event Time:
IONS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IONS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IONS alerts
High impacting Ionis Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
IONS
News
- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its price target raised by analysts at Stifel Nicolaus from $50.00 to $53.00. They now have a "hold" rating on the stock.MarketBeat
- FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen [Yahoo! Finance]Yahoo! Finance
- Ionis Pharmaceuticals (IONS) Soars 6.8%: Is Further Upside Left in the Stock? [Yahoo! Finance]Yahoo! Finance
- Ionis announces olezarsen FCS New Drug Application accepted for Priority Review and enrollment in Phase 3 sHTG program completed [Yahoo! Finance]Yahoo! Finance
- Ionis announces olezarsen FCS New Drug Application accepted for Priority Review and enrollment in Phase 3 sHTG program completedPR Newswire
IONS
Earnings
- 5/7/24 - Beat
IONS
Sec Filings
- 6/20/24 - Form 4
- 6/18/24 - Form 8-K
- 6/17/24 - Form 144
- IONS's page on the SEC website